• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下肢血栓性静脉炎的体内血小板活化:一项纵向研究

In vivo platelet activation in lower limbs thrombophlebitis. A longitudinal study.

作者信息

Bazzan M, Pannocchia A, Schinco P C, Della Dora N, Tamponi G

出版信息

Acta Haematol. 1984;72(4):239-44. doi: 10.1159/000206396.

DOI:10.1159/000206396
PMID:6239498
Abstract

Platelet activation in vivo was studied in patients with thrombophlebitis of the lower limbs. The parameters considered were the platelet aggregate ratio (PAR) and the beta-thromboglobulin (beta-tg) level, which were repeatedly evaluated from the disease onset up to 3 months later, during anticoagulating and antiaggregating therapy. A significant decrease of PAR was found, along with a significant rise of the beta-tg level at the onset of the disease, and these values slowly returned to normal on therapy course. The same parameters exceeded the normal range again when the patients arbitrarily suspended any drug assumption. The possible significance and implications of these findings are discussed.

摘要

对下肢血栓性静脉炎患者体内的血小板活化情况进行了研究。所考虑的参数为血小板聚集率(PAR)和β-血小板球蛋白(β-tg)水平,在抗凝和抗聚集治疗期间,从疾病发作开始直至3个月后对这些参数进行了反复评估。发现疾病发作时PAR显著降低,同时β-tg水平显著升高,并且这些值在治疗过程中缓慢恢复正常。当患者随意停用任何药物时,相同参数再次超出正常范围。讨论了这些发现的可能意义和影响。

相似文献

1
In vivo platelet activation in lower limbs thrombophlebitis. A longitudinal study.下肢血栓性静脉炎的体内血小板活化:一项纵向研究
Acta Haematol. 1984;72(4):239-44. doi: 10.1159/000206396.
2
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.动脉和静脉血栓栓塞:动力学特征及治疗评估
Thromb Diath Haemorrh. 1974 May 15;31(2):188-203.
3
beta-Thromboglobulin, platelet production time and pletelet function in vascular disease.β-血小板球蛋白、血小板生成时间与血管疾病中的血小板功能
Br J Haematol. 1979 Sep;43(1):127-36. doi: 10.1111/j.1365-2141.1979.tb03727.x.
4
Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.慢性肺源性心脏病患者的血小板活化。双嘧达莫治疗的效果。
Chin Med J (Engl). 1995 Feb;108(2):95-7.
5
The role of platelets in thrombotic and vascular disease.
Prog Cardiovasc Dis. 1979 Jul-Aug;22(1):31-52. doi: 10.1016/0033-0620(79)90002-1.
6
Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
J Lab Clin Med. 1985 Mar;105(3):397-402.
7
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.硬皮病患者循环血小板聚集体和β-血小板球蛋白水平升高。
Ann Intern Med. 1982 May;96(5):610-3. doi: 10.7326/0003-4819-96-5-610.
8
Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
Int J Clin Pharmacol Res. 1983;3(5):339-42.
9
A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.双嘧达莫和阿司匹林预防吸烟引起的冠心病男性血小板和内皮变化的试验。
Am J Cardiol. 1989 Jun 15;63(20):1450-4. doi: 10.1016/0002-9149(89)90006-4.
10
Platelet hyperaggregability in idiopathic recurrent deep vein thrombosis.特发性复发性深静脉血栓形成中的血小板高聚集性。
Circulation. 1976 Apr;53(4):687-91. doi: 10.1161/01.cir.53.4.687.